Exact Mass: 599.2955

Exact Mass Matches: 599.2955

Found 39 metabolites which its exact mass value is equals to given mass value 599.2955, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Lividomycin B

Quintomycin D.

C23H45N5O13 (599.3014)

A member of the class of lividomycins that is paromomycin in which the 2-amino-2-deoxyglucopyranosyl moiety is lacking the hydroxy group at position 3.

Phe Phe Met Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanoic acid

C29H41N7O5S (599.289)

Phe Phe Arg Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanoic acid

C29H41N7O5S (599.289)

Phe Met Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C29H41N7O5S (599.289)

Phe Met Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C29H41N7O5S (599.289)

Phe Arg Phe Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C29H41N7O5S (599.289)

Phe Arg Met Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C29H41N7O5S (599.289)

Met Phe Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C29H41N7O5S (599.289)

Met Phe Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C29H41N7O5S (599.289)

Met Arg Phe Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C29H41N7O5S (599.289)

Arg Phe Phe Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C29H41N7O5S (599.289)

Arg Phe Met Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C29H41N7O5S (599.289)

Arg Met Phe Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C29H41N7O5S (599.289)

BIBR 1087 SE

C32H37N7O5 (599.2856)

vanadium octaethylporphine oxide

C36H44N4OV (599.2955)

(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(4-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-[2-(1-piperidinyl)ethyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C34H41N5O3S (599.293)

(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(3-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-[2-(1-piperidinyl)ethyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C34H41N5O3S (599.293)

(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(3-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-[2-(1-piperidinyl)ethyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C34H41N5O3S (599.293)

(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(4-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-[2-(1-piperidinyl)ethyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C34H41N5O3S (599.293)

SHexCer 20:1;3O

C26H49NO12S (599.2975)

Lnaps 20:5/N-3:0

C29H46NO10P (599.2859)

Lnaps 3:0/N-20:5

C29H46NO10P (599.2859)

2-amino-3-[hydroxy-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxypropanoic acid

C29H46NO10P (599.2859)

2-amino-3-[hydroxy-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-pentanoyloxypropoxy]phosphoryl]oxypropanoic acid

C29H46NO10P (599.2859)

PE 20:5/4:1;O2

C29H46NO10P (599.2859)

PE 24:6;O2

C29H46NO10P (599.2859)

LNAPS 23:5

C29H46NO10P (599.2859)

ST 21:2;O7;HexNAc

C29H45NO12 (599.2942)

FMRF

C29H41N7O5S (599.289)

FMRF is a peptide consisting of 4 amino acid residues.

[(1e,7e,9e)-3-(2-aminoethyl)-1-(3-ethyl-6-oxo-2,3-dihydropyran-2-yl)-3,6-dihydroxy-10-{3-[(2-methylpropanoyl)oxy]cyclohexyl}deca-1,7,9-trien-4-yl]oxyphosphonic acid

C29H46NO10P (599.2859)

aristoloin ii

C36H41NO7 (599.2883)

{"Ingredient_id": "HBIN016814","Ingredient_name": "aristoloin ii","Alias": "NA","Ingredient_formula": "C36H41NO7","Ingredient_Smile": "CC1(CCCC2(C1CCC34C2CCC(C3)C(C4)(COC(=O)C5=CC6=C(C7=C5C(=CC8=CC=CC=C87)[N+](=O)[O-])OCO6)O)C)C","Ingredient_weight": "599.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1722","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101260746","DrugBank_id": "NA"}

5-amino-2-(aminomethyl)-6-({5-[(3,5-diamino-2-{[3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxycyclohexyl)oxy]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl}oxy)oxane-3,4-diol

C23H45N5O13 (599.3014)

[(2s,4s,5r,6r)-4-(chloromethyl)-4,5-dihydroxy-6-[(1e,3e)-5-[(2s,3s,5r,6r)-5-{[(2z,4s)-1-hydroxy-4-[(2-methylpropanoyl)oxy]pent-2-en-1-ylidene]amino}-3,6-dimethyloxan-2-yl]-3-methylpenta-1,3-dien-1-yl]oxan-2-yl]acetic acid

[(2s,4s,5r,6r)-4-(chloromethyl)-4,5-dihydroxy-6-[(1e,3e)-5-[(2s,3s,5r,6r)-5-{[(2z,4s)-1-hydroxy-4-[(2-methylpropanoyl)oxy]pent-2-en-1-ylidene]amino}-3,6-dimethyloxan-2-yl]-3-methylpenta-1,3-dien-1-yl]oxan-2-yl]acetic acid

C30H46ClNO9 (599.2861)

[4-(chloromethyl)-4,5-dihydroxy-6-{5-[5-({1-hydroxy-4-[(2-methylpropanoyl)oxy]pent-2-en-1-ylidene}amino)-3,6-dimethyloxan-2-yl]-3-methylpenta-1,3-dien-1-yl}oxan-2-yl]acetic acid

C30H46ClNO9 (599.2861)

[(1s,4r,9r,10r,13r,14r)-14-hydroxy-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]methyl 6-nitro-2h-phenanthro[3,4-d][1,3]dioxole-5-carboxylate

C36H41NO7 (599.2883)